John S. Lambert

Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine

Lynne Mofenson, John S. Lambert, E. Richard Stiehm et al. · New England Journal of Medicine · 1999 · 550 citations · Full text

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

Hans‐Jürgen Stellbrink, Chloe Orkin, José Ramón Arribas et al. · Clinical Infectious Diseases · 2010 · 409 citations · Full text

2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex

John S. Lambert, Mindell Seidlin, Richard C. Reichman et al. · New England Journal of Medicine · 1990 · 390 citations

Purine Analogue, Immunodeficiencies, Immunology +16

Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration

Davina Swan, Jean Long, Olívia Carr et al. · AIDS Patient Care and STDs · 2010 · 189 citations · Full text

Substance Use, Drug Treatment, Primary Care +20

Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin for Reducing Perinatal HIV Transmission from HIV‐Infected Women with Advanced Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185

E. Richard Stiehm, John S. Lambert, Lynne Mofenson et al. · The Journal of Infectious Diseases · 1999 · 149 citations · Full text